Cargando…

Exploiting the Therapeutic Potential of Endogenous Immunomodulatory Systems in Multiple Sclerosis—Special Focus on the Peroxisome Proliferator-Activated Receptors (PPARs) and the Kynurenines

Multiple sclerosis (MS) is a progressive neurodegenerative disease, characterized by autoimmune central nervous system (CNS) demyelination attributable to a disturbed balance between encephalitic T helper 1 (Th1) and T helper 17 (Th17) and immunomodulatory regulatory T cell (Treg) and T helper 2 (Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fakan, Bernadett, Szalardy, Levente, Vecsei, Laszlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358998/ https://www.ncbi.nlm.nih.gov/pubmed/30669473 http://dx.doi.org/10.3390/ijms20020426

Ejemplares similares

Predictors of localization, outcome, and etiology of spontaneous intracerebral hemorrhages: focus on cerebral amyloid angiopathy
por: Fakan, Bernadett, et al.
Publicado: (2020)

Correction to: Predictors of localization, outcome, and etiology of spontaneous intracerebral hemorrhages: focus on cerebral amyloid angiopathy
por: Fakan, Bernadett, et al.
Publicado: (2020)

Immunomodulatory Effects of Genetic Alterations Affecting the Kynurenine Pathway
por: Boros, Fanni A., et al.
Publicado: (2019)

Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives
por: Biernacki, Tamás, et al.
Publicado: (2020)

Kynurenines and Neurofilament Light Chain in Multiple Sclerosis
por: Pukoli, Dániel, et al.
Publicado: (2021)

Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines
por: Zádori, Dénes, et al.
Publicado: (2011)

Immunomodulatory actions of a kynurenine-derived endogenous electrophile
por: Carreño, Mara, et al.
Publicado: (2022)

Cluster headache and kynurenines
por: Tuka, Bernadett, et al.
Publicado: (2023)

Mitochondria, Oxidative Stress and the Kynurenine System, with a Focus on Ageing and Neuroprotection
por: Sas, Katalin, et al.
Publicado: (2018)

PACAP and its role in primary headaches
por: Edvinsson, Lars, et al.
Publicado: (2018)

Are Kynurenines Accomplices or Principal Villains in Dementia? Maintenance of Kynurenine Metabolism
por: Tanaka, Masaru, et al.
Publicado: (2020)

Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous System
por: Rajda, Cecilia, et al.
Publicado: (2015)

Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine
por: Nagy-Grócz, Gábor, et al.
Publicado: (2017)

Electron Transport Disturbances and Neurodegeneration: From Albert Szent-Györgyi's Concept (Szeged) till Novel Approaches to Boost Mitochondrial Bioenergetics
por: Szalárdy, Levente, et al.
Publicado: (2015)

Kynurenines, neurodegeneration and Alzheimer’s disease
por: Kincses, Zsigmond Tamas, et al.
Publicado: (2010)

Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy—Kynurenines Are Important Players
por: Sandi, Dániel, et al.
Publicado: (2021)

Metabolic Dysfunction and Peroxisome Proliferator-Activated Receptors (PPAR) in Multiple Sclerosis
por: Ferret-Sena, Véronique, et al.
Publicado: (2018)

Cerebrospinal Fluid Neurofilament Light Chain Is Associated with Kynurenine Pathway Metabolite Changes in Multiple Sclerosis
por: Rajda, Cecilia, et al.
Publicado: (2020)

Changing the Face of Kynurenines and Neurotoxicity: Therapeutic Considerations
por: Bohár, Zsuzsanna, et al.
Publicado: (2015)

Kynurenine Metabolites and Migraine: Experimental Studies and Therapeutic Perspectives
por: Fejes, Annamária, et al.
Publicado: (2011)

Searching for Peripheral Biomarkers in Neurodegenerative Diseases: The Tryptophan-Kynurenine Metabolic Pathway
por: Török, Nóra, et al.
Publicado: (2020)

Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines
por: Tanaka, Masaru, et al.
Publicado: (2020)

A Potential Interface between the Kynurenine Pathway and Autonomic Imbalance in Schizophrenia
por: Büki, Alexandra, et al.
Publicado: (2021)

Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Energy Homeostasis of Dairy Animals: Exploiting Their Modulation through Nutrigenomic Interventions
por: Hassan, Faiz-ul, et al.
Publicado: (2021)

Co-Players in Chronic Pain: Neuroinflammation and the Tryptophan-Kynurenine Metabolic Pathway
por: Tanaka, Masaru, et al.
Publicado: (2021)

The Tryptophan-Kynurenine Metabolic System Is Suppressed in Cuprizone-Induced Model of Demyelination Simulating Progressive Multiple Sclerosis
por: Polyák, Helga, et al.
Publicado: (2023)

Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR)
por: Tenenbaum, Alexander, et al.
Publicado: (2003)

Clinical relevance of depressed kynurenine pathway in episodic migraine patients: potential prognostic markers in the peripheral plasma during the interictal period
por: Tuka, Bernadett, et al.
Publicado: (2021)

PPARs and the Kynurenine Pathway in Melanoma—Potential Biological Interactions
por: Walczak, Katarzyna, et al.
Publicado: (2023)

The Genetic Link between Parkinson's Disease and the Kynurenine Pathway Is Still Missing
por: Török, Nóra, et al.
Publicado: (2015)

Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway
por: Tanaka, Masaru, et al.
Publicado: (2021)

Non-motor Behavioral Alterations of PGC-1α-Deficient Mice – A Peculiar Phenotype With Slight Male Preponderance and No Apparent Progression
por: Szalardy, Levente, et al.
Publicado: (2018)

Editorial: Multiple Implications of the Kynurenine Pathway in Inflammatory Diseases: Diagnostic and Therapeutic Applications
por: Mándi, Yvette, et al.
Publicado: (2022)

Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential Interactions
por: Zádor, Ferenc, et al.
Publicado: (2019)

The Effect of Systemic Nitroglycerin Administration on the Kynurenine Pathway in the Rat
por: Nagy-Grócz, Gábor, et al.
Publicado: (2017)

Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders
por: Cho, Min-Chul, et al.
Publicado: (2008)

Downregulation of peroxisome proliferator-activated receptors (PPARs) in nasal polyposis
por: Cardell, Lars-Olaf, et al.
Publicado: (2005)

The Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Pan-Cancer
por: Huang, Runzhi, et al.
Publicado: (2020)

Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Trophoblast Functions
por: Peng, Lin, et al.
Publicado: (2021)

Mitochondrial Impairment: A Common Motif in Neuropsychiatric Presentation? The Link to the Tryptophan–Kynurenine Metabolic System
por: Tanaka, Masaru, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_css7169dq0g18h3i7bv6ohofqs